Načítá se...
How close are we to therapies for Sanfilippo disease?
Sanfilippo disease is one of mucopolysaccharidoses (MPS), a group of lysosomal storage diseases characterized by accumulation of partially degraded glycosaminoglycans (GAGs). It is classified as MPS type III, though it is caused by four different genetic defects, determining subtypes A, B, C and D....
Uloženo v:
| Vydáno v: | Metab Brain Dis |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769821/ https://ncbi.nlm.nih.gov/pubmed/28921412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-017-0111-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|